$BCBP
BCB BANCORP INC

2020 Q2 Form 10-Q Financial Statement

#000122845420000010 Filed on August 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q4 2019 Q2
Revenue $27.21M $30.97M $30.74M
YoY Change -11.5% 1.57% 19.64%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $800.0K $800.0K $700.0K
YoY Change 14.29% 0.0% 0.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $9.215M $10.89M $9.877M
YoY Change -6.7% 16.87% 73.1%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $3.847M $7.312M $7.544M
YoY Change -49.01% -4.1% 114.75%
Income Tax $1.121M $2.188M $2.317M
% Of Pretax Income 29.14% 29.92% 30.71%
Net Earnings $2.726M $5.124M $5.227M
YoY Change -47.85% -1.91% 125.98%
Net Earnings / Revenue 10.02% 16.55% 17.0%
Basic Earnings Per Share $0.14 $0.29 $0.30
Diluted Earnings Per Share $0.14 $0.29 $0.30
COMMON SHARES
Basic Shares Outstanding 17.18M 16.48M 16.41M
Diluted Shares Outstanding 17.18M 16.47M

Balance Sheet

Concept 2020 Q2 2019 Q4 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $412.2M $261.2M $227.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $18.65M $19.92M $19.48M
YoY Change -4.26% -1.84% -7.67%
Goodwill $5.200M $5.200M
YoY Change -0.61%
Intangibles
YoY Change
Long-Term Investments $12.68M $2.500M $5.901M
YoY Change 114.93% -67.41% -27.15%
Other Assets $11.30M $11.20M $13.00M
YoY Change -13.08% -17.65% 13.04%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.987B $2.907B $2.738B
YoY Change 9.08% 8.7% 8.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $13.50M $26.80M $14.70M
YoY Change -8.16%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.50M $26.80M $14.70M
YoY Change -8.16%
LONG-TERM LIABILITIES
Long-Term Debt $36.90M $36.80M $36.70M
YoY Change 0.54% 0.55% 795.12%
Other Long-Term Liabilities $10.40M -$3.400M $11.50M
YoY Change -9.57% -129.82% -14.81%
Total Long-Term Liabilities $47.30M $33.40M $48.20M
YoY Change -1.87% -30.42% 173.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.50M $26.80M $14.70M
Total Long-Term Liabilities $47.30M $33.40M $48.20M
Total Liabilities $2.746B $2.668B $2.517B
YoY Change 9.09% 7.82% 8.37%
SHAREHOLDERS EQUITY
Retained Earnings $48.10M $48.43M $43.35M
YoY Change 10.96% 26.1%
Common Stock $191.2M $190.3M $176.8M
YoY Change 8.14% 8.43%
Preferred Stock $27.96M $25.02M $25.02M
YoY Change 11.75% 26.95%
Treasury Stock (at cost) $26.92M $22.05M $22.05M
YoY Change 22.09% -22.15%
Treasury Stock Shares $2.467M $1.967M $1.967M
Shareholders Equity $241.0M $239.5M $221.2M
YoY Change
Total Liabilities & Shareholders Equity $2.987B $2.907B $2.738B
YoY Change 9.08% 8.7% 8.8%

Cashflow Statement

Concept 2020 Q2 2019 Q4 2019 Q2
OPERATING ACTIVITIES
Net Income $2.726M $5.124M $5.227M
YoY Change -47.85% -1.91% 125.98%
Depreciation, Depletion And Amortization $800.0K $800.0K $700.0K
YoY Change 14.29% 0.0% 0.0%
Cash From Operating Activities -$3.100M $9.300M $4.200M
YoY Change -173.81% -64.91% -940.0%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$300.0K -$500.0K
YoY Change -80.0% -62.5% -16.67%
Acquisitions
YoY Change
Other Investing Activities -$223.2M $86.10M $13.30M
YoY Change -1778.2% -224.6% -107.89%
Cash From Investing Activities -$223.3M $85.70M $12.80M
YoY Change -1844.53% -222.78% -107.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 43.50M 78.70M 17.10M
YoY Change 154.39% 146.71% -91.96%
NET CHANGE
Cash From Operating Activities -3.100M 9.300M 4.200M
Cash From Investing Activities -223.3M 85.70M 12.80M
Cash From Financing Activities 43.50M 78.70M 17.10M
Net Change In Cash -182.9M 173.7M 34.10M
YoY Change -636.36% -1623.68% -20.88%
FREE CASH FLOW
Cash From Operating Activities -$3.100M $9.300M $4.200M
Capital Expenditures -$100.0K -$300.0K -$500.0K
Free Cash Flow -$3.000M $9.600M $4.700M
YoY Change -163.83% -64.84% 4600.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001228454
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y8M23D
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-50275
dei Entity Registrant Name
EntityRegistrantName
BCB Bancorp, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NJ
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0065262
dei Entity Address Address Line1
EntityAddressAddressLine1
104-110 Avenue C
dei Entity Address City Or Town
EntityAddressCityOrTown
Bayonne
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07002
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
823-0700
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
BCBP
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17057368
CY2020Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
18799000
CY2019Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
24985000
CY2020Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
393450000
CY2019Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
525368000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
412249000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
550353000
CY2020Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2019Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
127518000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
91613000
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
12683000
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2500000
CY2020Q2 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
760000
CY2019Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
917000
CY2020Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
28842000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
23734000
CY2020Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2343593000
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2178407000
CY2020Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
13529000
CY2019Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
13821000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18653000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19920000
CY2020Q2 us-gaap Interest Receivable
InterestReceivable
16569000
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
8318000
CY2020Q2 us-gaap Other Real Estate
OtherRealEstate
1623000
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
1623000
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11339000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11180000
CY2020Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5519000
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5552000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13335000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13246000
CY2020Q2 us-gaap Other Assets
OtherAssets
8771000
CY2019Q4 us-gaap Other Assets
OtherAssets
9283000
CY2020Q2 us-gaap Assets
Assets
2986876000
CY2019Q4 us-gaap Assets
Assets
2907468000
CY2020Q2 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
390912000
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
271702000
CY2020Q2 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2051321000
CY2019Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2090361000
CY2020Q2 us-gaap Deposits
Deposits
2442233000
CY2019Q4 us-gaap Deposits
Deposits
2362063000
CY2020Q2 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
242800000
CY2019Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
245800000
CY2020Q2 us-gaap Subordinated Debt
SubordinatedDebt
36926000
CY2019Q4 us-gaap Subordinated Debt
SubordinatedDebt
36810000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
13521000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13380000
CY2020Q2 us-gaap Other Liabilities
OtherLiabilities
10377000
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
9942000
CY2020Q2 us-gaap Liabilities
Liabilities
2745857000
CY2019Q4 us-gaap Liabilities
Liabilities
2667995000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8634
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8634
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
8340
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
8340
CY2020Q2 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
27956000
CY2019Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
25016000
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19524586
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19484046
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17057368
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17516828
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
191160000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
190294000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
48097000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
48429000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
52937000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
56867000
CY2020Q2 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
494000
CY2019Q2 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
738000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
1057000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
1508000
CY2020Q2 us-gaap Interest Income Other
InterestIncomeOther
246000
CY2019Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
7957000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
16108000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
15636000
CY2020Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1852000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
724000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2218000
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2467218
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1967218
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
26918000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
22048000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
241019000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
239473000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2986876000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2907468000
CY2020Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
26123000
CY2019Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
28634000
CY2019Q2 us-gaap Interest Income Other
InterestIncomeOther
197000
us-gaap Interest Income Other
InterestIncomeOther
254000
us-gaap Interest Income Other
InterestIncomeOther
325000
CY2020Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
343000
CY2019Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1173000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
2377000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
2520000
CY2020Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
27206000
CY2019Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
30742000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
56625000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
61220000
CY2020Q2 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
1562000
CY2019Q2 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
1750000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
3770000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
3326000
CY2020Q2 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
106000
CY2019Q2 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
110000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
211000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
223000
CY2020Q2 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
5695000
CY2019Q2 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
6097000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
12127000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
12087000
CY2020Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
7363000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
3817000
CY2020Q2 us-gaap Interest Expense
InterestExpense
9215000
CY2019Q2 us-gaap Interest Expense
InterestExpense
9877000
us-gaap Interest Expense
InterestExpense
19856000
us-gaap Interest Expense
InterestExpense
19453000
CY2019Q2 us-gaap Noninterest Income
NoninterestIncome
1328000
us-gaap Noninterest Income
NoninterestIncome
1791000
us-gaap Noninterest Income
NoninterestIncome
2988000
CY2019Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1920000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
3748000
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
17991000
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20865000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
36769000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
41767000
CY2020Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3300000
CY2019Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
755000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4800000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1644000
CY2020Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
14691000
CY2019Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
20110000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
31969000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
40123000
CY2020Q2 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
537000
CY2019Q2 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
802000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1263000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1685000
CY2020Q2 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
57000
CY2019Q2 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
437000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
118000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
755000
bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
107000
CY2019Q2 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
45000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
53000
CY2020Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
40000
CY2019Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
21000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
40000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
21000
CY2020Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
442000
CY2019Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-26000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
2000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
265000
CY2020Q2 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
32000
CY2019Q2 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
49000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
368000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
102000
CY2020Q2 us-gaap Noninterest Income
NoninterestIncome
1108000
CY2020Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5682000
CY2019Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6918000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
13071000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
13833000
CY2020Q2 us-gaap Occupancy Net
OccupancyNet
2910000
CY2019Q2 us-gaap Occupancy Net
OccupancyNet
2649000
us-gaap Occupancy Net
OccupancyNet
5734000
us-gaap Occupancy Net
OccupancyNet
5279000
CY2020Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
951000
CY2019Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
731000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1889000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1452000
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
398000
CY2019Q2 us-gaap Professional Fees
ProfessionalFees
473000
us-gaap Professional Fees
ProfessionalFees
868000
us-gaap Professional Fees
ProfessionalFees
1006000
CY2020Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
365000
CY2019Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
316000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
723000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
634000
CY2020Q2 bcbp Regulatory Assessments
RegulatoryAssessments
251000
CY2019Q2 bcbp Regulatory Assessments
RegulatoryAssessments
417000
bcbp Regulatory Assessments
RegulatoryAssessments
572000
bcbp Regulatory Assessments
RegulatoryAssessments
874000
CY2020Q2 us-gaap Advertising Expense
AdvertisingExpense
26000
CY2019Q2 us-gaap Advertising Expense
AdvertisingExpense
123000
us-gaap Advertising Expense
AdvertisingExpense
87000
us-gaap Advertising Expense
AdvertisingExpense
196000
CY2020Q2 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
21000
CY2019Q2 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
124000
us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
47000
us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
108000
CY2020Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1348000
CY2019Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2143000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
3325000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
4289000
CY2020Q2 us-gaap Noninterest Expense
NoninterestExpense
11952000
CY2019Q2 us-gaap Noninterest Expense
NoninterestExpense
13894000
us-gaap Noninterest Expense
NoninterestExpense
26316000
us-gaap Noninterest Expense
NoninterestExpense
27671000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3847000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7544000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7444000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15440000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1121000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2317000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2197000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4762000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2726000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
5227000
us-gaap Net Income Loss
NetIncomeLoss
5247000
us-gaap Net Income Loss
NetIncomeLoss
10678000
CY2020Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
341000
CY2019Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
342000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
682000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
659000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2385000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4885000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4565000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10019000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17179000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16413000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17340000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16245000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17183000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16471000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17366000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16290000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2726000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
5227000
us-gaap Net Income Loss
NetIncomeLoss
5247000
us-gaap Net Income Loss
NetIncomeLoss
10678000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
603000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1935000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
3912000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
4201000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
150000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
485000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
970000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1054000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
453000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1450000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
559000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4870000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
682000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4688000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
219000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
241019000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2942000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3147000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3179000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6677000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8189000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13825000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
239473000
us-gaap Net Income Loss
NetIncomeLoss
5247000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2942000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3080000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
140000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
240638000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2726000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
453000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3080000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
280000
CY2020Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
372942
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3583000
CY2020Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
341000
CY2020Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2351000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
117000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
241019000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
200215000
us-gaap Net Income Loss
NetIncomeLoss
10678000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3147000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
397000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
659000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4326000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
152000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
221153000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
216718000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
5227000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1450000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
207000
CY2019Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
342000
CY2019Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2190000
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
83000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
221153000
us-gaap Net Income Loss
NetIncomeLoss
5247000
us-gaap Net Income Loss
NetIncomeLoss
10678000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1469000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1424000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
1148000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
1542000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4800000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1644000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1129000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-569000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
7093000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
8560000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
7368000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
10468000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
118000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
755000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
53000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
40000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
21000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
2000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
265000
bcbp Gain Loss On Bulk Sale Of Impaired Loans Held In Portfolio
GainLossOnBulkSaleOfImpairedLoansHeldInPortfolio
107000
us-gaap Share Based Compensation
ShareBasedCompensation
559000
us-gaap Share Based Compensation
ShareBasedCompensation
397000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
8251000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
937000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-512000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1311000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-216000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
288000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
651000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
34000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2609000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10813000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
13631000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
8328000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
56515000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.36
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1153000
us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
1058000
bcbp Proceeds From Sale Of Impaired Loans
ProceedsFromSaleOfImpairedLoans
402000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
564000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
2057000
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
48360000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
120091000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
22312000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
202000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
613000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-292000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
416000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-210681000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12649000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
80170000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
27498000
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
27000000
us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
30000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4870000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4688000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4326000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
682000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
659000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
93000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6391000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
3080000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
5310000
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
140000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
69968000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34214000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-138104000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32378000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
550353000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195264000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
412249000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227642000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2964000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6342000
us-gaap Interest Paid Net
InterestPaidNet
20072000
us-gaap Interest Paid Net
InterestPaidNet
19165000
us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
907000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
us-gaap Reclassifications
Reclassifications
<span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 3 – Reclassification </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain amounts as of December 31, 2019 and for the three-month and six-month periods ended June 30, 2019 have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.</span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span>
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
81278
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
23809
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
12.46
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
57469
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.76
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
67321
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
47618
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.46
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
114939
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.86
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
411000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1200975
CY2019 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
CY2019 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.45
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Exercised Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExercisedExercisePriceRange
10.55
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.55
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1200475
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.45
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
565238
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
635237
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1300000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1104600
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
CY2018 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2385000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4885000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
98875
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRange
12.46
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1000
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Forfeited Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsForfeitedExercisePriceRange
10.55
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.55
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1202475
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.45
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
268633
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16328
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
58302
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
58302
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
45479
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2385000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17179000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4885000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16413000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4000
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
58000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2385000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17183000
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4885000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16471000
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4565000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10019000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4565000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17340000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10019000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16245000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
26000
CY2019Q4 bcbp Available For Sale Securities Debt Maturities After Ten Years Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsGrossUnrealizedGains
574000
CY2019Q4 bcbp Available For Sale Securities Debt Maturities After Ten Years Gross Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsGrossUnrealizedLosses
1196000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
86647000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
92266000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
615000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1268000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
91613000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
45000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4565000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17366000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10019000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16290000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2020Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
482000
CY2019Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-47000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
42000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
286000
CY2020Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
40000
CY2019Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
21000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
40000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
21000
CY2020Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
442000
CY2019Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-26000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
2000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
265000
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
124259000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3333000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
74000
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
127518000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
3431000
CY2019Q4 bcbp Available For Sale Securities Debt Maturities Year Two Through Year Five Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughYearFiveGrossUnrealizedGains
8000
CY2019Q4 bcbp Available For Sale Securities Debt Maturities Year Two Through Year Five Gross Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughYearFiveGrossUnrealizedLosses
72000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
3367000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1566000
CY2019Q4 bcbp Available For Sale Securities Debt Maturities Year Six Through Ten Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesYearSixThroughTenGrossUnrealizedGains
33000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1599000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
87269000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
1670000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
19000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
1945000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
55000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
3615000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
74000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
13073000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
656000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
23212000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
612000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
36285000
CY2019Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
1268000
CY2020Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2376256000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2203315000
CY2020Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
3821000
CY2019Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
1174000
CY2020Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
28842000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
23734000
CY2020Q2 bcbp Total Deductions From Gross Loans
TotalDeductionsFromGrossLoans
32663000
CY2019Q4 bcbp Total Deductions From Gross Loans
TotalDeductionsFromGrossLoans
24908000
CY2020Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2343593000
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2178407000
CY2020Q2 bcbp Lines Of Credit And Ppp Loans Receivable Cares Act
LinesOfCreditAndPppLoansReceivableCaresAct
127500000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
25534000
CY2020Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3300000
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
28842000
CY2020Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
26838000
CY2020Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2349418000
CY2020Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2376256000
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
3401000
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
25441000
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
28842000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23734000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
4000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
312000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4800000
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
28842000
CY2019Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23004000
CY2019Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
30000
CY2019Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
755000
CY2019Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23789000
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22359000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
256000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
42000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1644000
CY2019Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23789000
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22359000
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
743000
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
49000
CY2019 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2069000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23734000
CY2019Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
26912000
CY2019Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2176403000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2203315000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
3264000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
20470000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23734000
CY2020Q2 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
17471000
CY2020Q2 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
273000
CY2019Q2 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
29926000
CY2019Q2 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
290000
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
18176000
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
476000
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
30930000
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
606000
CY2020Q2 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
7493000
CY2020Q2 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
63000
CY2019Q2 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
8040000
CY2019Q2 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
93000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
7415000
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
131000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
8517000
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
182000
CY2020Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
18851000
CY2020Q2 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
29142000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
19647000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
29082000
CY2020Q2 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
7987000
CY2020Q2 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
10797000
CY2020Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3401000
CY2019Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
7265000
CY2019Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
10270000
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3264000
CY2020Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
18851000
CY2020Q2 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
29142000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
19647000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
29082000
CY2020Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
26838000
CY2020Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
39939000
CY2020Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3401000
CY2019Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
26912000
CY2019Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
39352000
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3264000
CY2020Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
17254000
CY2019Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
17732000
CY2019Q2 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2020Q2 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
208352
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
1
us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
1200000
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
3
us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2020Q2 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2020Q2 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
10003000
CY2020Q2 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
2366253000
CY2020Q2 us-gaap Notes Receivable Net
NotesReceivableNet
2376256000
CY2020Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
795000
CY2020Q2 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Acquired During Period At Acquisition At Fair Value
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAcquiredDuringPeriodAtAcquisitionAtFairValue
1100000
CY2019Q4 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Acquired During Period At Acquisition At Fair Value
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAcquiredDuringPeriodAtAcquisitionAtFairValue
3500000
CY2020Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
4495000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
4160000
us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
509000
us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
967000
bcbp Nonaccrual Loans Interest Income Cash Basis Method
NonaccrualLoansInterestIncomeCashBasisMethod
509000
bcbp Nonaccrual Loans Interest Income Cash Basis Method
NonaccrualLoansInterestIncomeCashBasisMethod
1100000
CY2020Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
795000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
14522000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
2188793000
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
2203315000
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
795000
CY2020Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2376256000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2203315000
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0
CY2020Q2 us-gaap Goodwill
Goodwill
5200000
CY2019Q4 us-gaap Goodwill
Goodwill
5200000
bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2019Q2 bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2020Q2 bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2020Q2 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
4586000
CY2020Q2 us-gaap Other Real Estate
OtherRealEstate
1623000
CY2019Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
4001000
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
1623000
CY2020Q2 us-gaap Other Real Estate
OtherRealEstate
1623000
bcbp Lessee Operating Leases Number
LesseeOperatingLeasesNumber
28
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
854000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
812000
us-gaap Operating Lease Cost
OperatingLeaseCost
1709000
us-gaap Operating Lease Cost
OperatingLeaseCost
1562000
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
196000
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
170000
us-gaap Variable Lease Cost
VariableLeaseCost
398000
us-gaap Variable Lease Cost
VariableLeaseCost
302000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13335000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13246000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2731000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2590000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10790000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10790000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
13521000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
13380000
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M12D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M8D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0309
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0316
CY2020Q2 bcbp Operating And Finance Lease Liabilities Payments Due In Next Rolling Twelve Months
OperatingAndFinanceLeaseLiabilitiesPaymentsDueInNextRollingTwelveMonths
2731000
CY2019Q4 bcbp Operating And Finance Lease Liabilities Payments Due In Next Rolling Twelve Months
OperatingAndFinanceLeaseLiabilitiesPaymentsDueInNextRollingTwelveMonths
2590000
CY2020Q2 bcbp Operating And Finance Lease Liabilities Payments Due In Next Rolling Years Two And Three
OperatingAndFinanceLeaseLiabilitiesPaymentsDueInNextRollingYearsTwoAndThree
4528000
CY2019Q4 bcbp Operating And Finance Lease Liabilities Payments Due In Next Rolling Years Two And Three
OperatingAndFinanceLeaseLiabilitiesPaymentsDueInNextRollingYearsTwoAndThree
4713000
CY2020Q2 bcbp Operating And Finance Lease Liabilities Payments Due In Next Rolling Years Four And Five
OperatingAndFinanceLeaseLiabilitiesPaymentsDueInNextRollingYearsFourAndFive
2615000
CY2019Q4 bcbp Operating And Finance Lease Liabilities Payments Due In Next Rolling Years Four And Five
OperatingAndFinanceLeaseLiabilitiesPaymentsDueInNextRollingYearsFourAndFive
2736000
CY2020Q2 bcbp Operating And Finance Lease Liabilities Payments Due In Next Rolling After Year Five
OperatingAndFinanceLeaseLiabilitiesPaymentsDueInNextRollingAfterYearFive
3647000
CY2019Q4 bcbp Operating And Finance Lease Liabilities Payments Due In Next Rolling After Year Five
OperatingAndFinanceLeaseLiabilitiesPaymentsDueInNextRollingAfterYearFive
3341000
CY2020Q2 bcbp Operating And Finance Lease Liabilities Payments Due
OperatingAndFinanceLeaseLiabilitiesPaymentsDue
13521000
CY2019Q4 bcbp Operating And Finance Lease Liabilities Payments Due
OperatingAndFinanceLeaseLiabilitiesPaymentsDue
13380000

Files In Submission

Name View Source Status
0001228454-20-000010-index-headers.html Edgar Link pending
0001228454-20-000010-index.html Edgar Link pending
0001228454-20-000010.txt Edgar Link pending
0001228454-20-000010-xbrl.zip Edgar Link pending
bcbp-20200630.xsd Edgar Link pending
bcbp-20200630x10q.htm Edgar Link pending
bcbp-20200630x10q_htm.xml Edgar Link completed
bcbp-20200630xex31_1.htm Edgar Link pending
bcbp-20200630xex31_2.htm Edgar Link pending
bcbp-20200630xex32.htm Edgar Link pending
bcbp-20200630_cal.xml Edgar Link unprocessable
bcbp-20200630_def.xml Edgar Link unprocessable
bcbp-20200630_lab.xml Edgar Link unprocessable
bcbp-20200630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending